Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04138875 |
| Title | A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) |
| Recruitment | Withdrawn |
| Gender | |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Mayo Clinic |
| Indications | |
| Therapies | |
| Age Groups: | |
| Covered Countries | USA |